Literature DB >> 10910144

Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector.

M K Brenner1, H Heslop, R Krance, M Horowitz, D Strother, J Nuchtern, B Grilley, E Martingano, K Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10910144     DOI： 10.1089/10430340050057549

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  8 in total

Review 1.  Immunotherapy in pediatric malignancies: current status and future perspectives.

Authors:  Christian M Capitini; Mario Otto; Kenneth B DeSantes; Paul M Sondel
Journal:  Future Oncol       Date:  2014       Impact factor: 3.404

Review 2.  Advances in chimeric antigen receptor immunotherapy for neuroblastoma.

Authors:  Andras Heczey; Chrystal U Louis
Journal:  Discov Med       Date:  2013-12       Impact factor: 2.970

3.  A distinct "side population" of cells with high drug efflux capacity in human tumor cells.

Authors:  C Hirschmann-Jax; A E Foster; G G Wulf; J G Nuchtern; T W Jax; U Gobel; M A Goodell; M K Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

Review 4.  Polymeric oncolytic adenovirus for cancer gene therapy.

Authors:  Joung-Woo Choi; Young Sook Lee; Chae-Ok Yun; Sung Wan Kim
Journal:  J Control Release       Date:  2015-10-23       Impact factor: 9.776

5.  Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.

Authors:  Qiang Zhou; Bryon D Johnson; Rimas J Orentas
Journal:  Cell Immunol       Date:  2007-06-01       Impact factor: 4.868

6.  Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives.

Authors:  Ettore Biagi; Catherine Bollard; Raphael Rousseau; Malcolm Brenner
Journal:  J Biomed Biotechnol       Date:  2003

Review 7.  Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future.

Authors:  Fabio Morandi; Federica Sabatini; Marina Podestà; Irma Airoldi
Journal:  Vaccines (Basel)       Date:  2021-01-13

8.  Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity.

Authors:  I Airoldi; R Meazza; M Croce; E Di Carlo; T Piazza; C Cocco; T D'Antuono; V Pistoia; S Ferrini; M V Corrias
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.